BGM Group Ltd. (BGM) vs MaxCyte, Inc. (MXCT)
A side-by-side comparison of BGM Group Ltd. and MaxCyte, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BGM
BGM Group Ltd.
$9.17HealthcareDelayed quote: Oct 6, 2026, 11:10 AM EDT
MXCT
MaxCyte, Inc.
$1.07HealthcareDelayed quote: Oct 6, 2026, 11:05 AM EDT
Total return — BGM vs MXCT
growth of $100 · dividends reinvested · last 2yBGM -94.3% (-76.2%/yr)MXCT -75.3% (-50.3%/yr)MXCT compounded faster over this window
BGM MXCT
BGM vs MXCT: by the numbers
- •BGM is the larger company ($116M vs $114M market cap).
- •Both run net losses; BGM's is the smaller (-52.59% vs -114.77% net margin).
- •MXCT grew revenue faster over the past five years (1.46% vs -5.39% CAGR).
Metrics side by side
Valuation
| Metric | BGM | MXCT |
|---|---|---|
| P/S ratio | N/A | 3.67 |
| P/B ratio | 0.29 | 0.72 |
Profitability
| Metric | BGM | MXCT |
|---|---|---|
| Gross margin | 12.79% | 79.43% |
| Operating margin | -33.18% | -137.12% |
| Net margin | -52.59% | -114.77% |
| ROE | -5.10% | -22.45% |
| ROIC | -3.19% | -19.83% |
Growth (annualized)
| Metric | BGM | MXCT |
|---|---|---|
| Revenue CAGR (5Y) | -5.39% | 1.46% |
| Total return CAGR (5Y) | N/A | -37.32% |
Frequently asked
- Which has grown faster, BGM or MXCT?
- Over the past five years, MXCT grew revenue faster — BGM at a -5.39% CAGR versus MXCT at 1.46%.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.